Niraj Sharma: Can We Really Stop Anticoagulation After AF Ablation?
Niraj Sharma, Cardiac Electrophysiologist/Cardiologist at Northside Hospital, shared on LinkedIn:
”Can We Really Stop Anticoagulation After AF Ablation?
“Successful ablation” does not equal stroke immunity.
The final EP Edge Journal Watch of 2025 (December | Issue 4) takes a hard, data-driven look at one of the most debated questions in AF care—and the answer is far less clear than many think.
Inside:
- A study-by-study breakdown of post-ablation anticoagulation trials
- Why aspirin keeps showing up—and why that matters
Signals from metabolic drug trials that may quietly influence stroke risk
Why men and women aren’t biologically the same, including key differences in sinus node function
Where evidence is often over-interpreted in real-world practice
No dogma. No shortcuts. Just what the data actually show.
Next up: the MEGA Marijuana and Cardiac Electrophysiology Issue—THC, arrhythmias, and autonomic effects you won’t find in guidelines.
Follow EP EDGE Newsletter: packed into one powerful monthly read.
Subscribe to EP Edge Journal Watch and read here.
Graphics plus References and full deep dive inside.
Podcast: EP EDGE (Apple, Spotify, You tube, Amazon….)”
Read the Issue 4 here.

Stay updated with Hemostasis Today.
-
Aug 11, 2026, 07:50When Access to Care Changes Everything – WFH
-
Aug 11, 2026, 07:35Kuldeep Singh Bhadauria: Building the Future of Hemophilia Care in India
-
Aug 11, 2026, 07:28Archil Jaliashvili: When Every Minute Matters Time Becomes a Therapy
-
Aug 11, 2026, 07:05Mavis Agnes Kisakye: Building Sustainable Transition Pathways in Hemophilia Care
-
Aug 11, 2026, 06:48Rishdha Roshad: What Happens to the Brain During Cardiopulmonary Bypass?
-
Aug 11, 2026, 05:53Isaac Okello: Strengthening Sickle Cell Advocacy in Uganda
-
Aug 11, 2026, 05:38Rami Unterman: A Simple New Biomarker for Fibrotic ILDs
-
Aug 11, 2026, 04:10Haroun Gajraj: CLaCS vs Sclerotherapy – What Does the Evidence Show
-
Aug 11, 2026, 02:54Tareq Abadl: The Ultimate Guide to Clinically Significant Antibodies